Table 2.
no. | hMC1R
|
hMC3R
|
hMC4R
|
hMC5R
|
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
IC50, nM | % BE | EC50, nM | % max effect | IC50, nM | % BE | EC50, nM | % max effect | IC50, nM | % BE | EC50, nM | % max effect | IC50, nM | % BE | EC50, nM | % max effect | |
1 | 0.30 ± 0.02 | 100 | 3.0 ± 0.2 | 70 | 5.0 ± 0.6 | 100 | 300 ± 6 | 6 | 6.0 ± 1 | 100 | 630 ± 70 | 18 | 3.5 ± 0.5 | 100 | NA | 6 |
2 | 82 ± 7 | 100 | 4.6 ± 0.9 | 100 | 4.1 ± 0.4 | 100 | 5.0 ± 0.4 | 100 | 5.0 ± 0.4 | 100 | 23 ± 3 | 90 | 18 ± 3 | 100 | 16 ± 1 | 82 |
3 | NB | 0 | >1000 | 100 | 18 ± 2 | 33 | NA | 0 | NB | 0 | NA | 0 | NB | 0 | NA | 0 |
4 | 137 ± 11 | 100 | 604 ± 74 | 100 | 17 ± 1 | 26 | NA | 0 | >1000 | 47 | NA | 0 | NB | 0 | NA | 0 |
5 | 24 ± 3 | 100 | 4.5 ± 0.4 | 100 | >1000 | 45 | >1000 | 50 | 210 ± 5 | 58 | 71 ± 8 | 54 | NB | 0 | NA | 0 |
6 | 16 ± 2 | 29 | NA | 0 | 117 ± 24 | 32 | NA | 0 | NB | 0 | NA | 0 | 0.42 ± 0.07 | 32 | NA | 0 |
7 | 1.1 ± 0.1 | 32 | >1000 | 100 | >1000 | 47 | >1000 | 100 | 6.7 ± 0.9 | 36 | 200 ± 25 | 100 | NB | 0 | NA | 0 |
8 | >1000 | 52 | 40 ± 6 | 100 | 118 ± 14 | 73 | 521 ± 72 | 100 | 360 ± 42 | 62 | 128 ± 13 | 78 | 36 ± 1 | 47 | >1000 | 100 |
9 | 23 ± 2 | 100 | 31 ± 6 | 100 | 56 ± 3 | 69 | >1000 | 100 | 20 ± 1 | 86 | 444 ± 69 | 100 | 254 ± 41 | 38 | NA | 0 |
10 | 42 ± 7 | 100 | 8 ± 1.8 | 100 | >1000 | 53 | >1000 | 100 | 68 ± 11 | 100 | 178 ± 23 | 100 | >1000 | 60 | NA | 0 |
11 | 1000 ± 20 | 100 | 300 ± 30 | 100 | 71 ± 10 | 100 | 700 ± 89 | 100 | 760 ± 80 | 100 | 710 ± 70 | 100 | 2200 ± 200 | 100 | 550 ± 60 | 100 |
12 | 1.2 ± 0.2 | 100 | 70 ± 10 | 100 | 40 ± 10 | 100 | 520 ± 50 | 38 | 45 ± 5 | 100 | 65 ± 12 | 76 | 330 ± 57 | 100 | 390 ± 25 | 73 |
13 | 0.5 ± 0.01 | 100 | 1.5 ± 0.1 | 100 | 2.0 ± 0.02 | 100 | 2.0 ± 0.2 | 100 | 1.2 ± 0.2 | 100 | 1.4 ± 0.1 | 100 | 2.4 ± 0.3 | 100 | 1.9 ± 0.2 | 100 |
14 | 0.4 ± 0.01 | 100 | 0.7 ± 0.01 | 100 | 30 ± 3.9 | 100 | 6.7 ± 1 | 100 | 5 ± 1 | 100 | 2.1 ± 0.6 | 100 | 18 ± 2 | 100 | 8.1 ± 1.5 | 100 |
15 | 0.01 | 100 | 0.01 | 100 | 3.3 ± 0.3 | 100 | 0.8 ± 0.1 | 100 | 0.4 ± 0.02 | 100 | 0.2 ± 0.04 | 100 | 2.2 ± 0.5 | 100 | 1 ± 0.3 | 100 |
a IC | is the | peptide at 50% | fic | (N = 4). | % BE | the | of [125 | α-MSH | at 10 μM. | means | that 0% of [125 | -MSH |
IC50 is the concentration of peptide at 50% specific binding (N = 4). % BE is the percentage of [125I]NDP-α-MSH displacement at 10 μM. NB means that 0% of [125I]NDP-α-MSH displacement was observed at 10 μM. EC50 is the effective concentration of peptide that could generate 50% maximal intracellular cAMP accumulation (N = 4). % max effect is the percentage of cAMP produced at a ligand concentration of 10 μM, in relation to MT-II. NA indicates 0% cAMP accumulation observed at 10 μM. The peptides were tested over a range of concentrations from 10−10 to 10−5 M. Compounds 1 and 11–15 were previously published data and are included for comparison.